Xiaoyin Lai

475 total citations
10 papers, 408 citations indexed

About

Xiaoyin Lai is a scholar working on Molecular Biology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xiaoyin Lai has authored 10 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Neurology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xiaoyin Lai's work include Circular RNAs in diseases (3 papers), Extracellular vesicles in disease (2 papers) and MicroRNA in disease regulation (2 papers). Xiaoyin Lai is often cited by papers focused on Circular RNAs in diseases (3 papers), Extracellular vesicles in disease (2 papers) and MicroRNA in disease regulation (2 papers). Xiaoyin Lai collaborates with scholars based in China and United States. Xiaoyin Lai's co-authors include Longxuan Li, Xuelian Yang, Liying Cai, Yufeng Jiang, Mei Jiang, Hai‐Feng Ji, Feifei Wu, Limin Xu, Mingming Jin and Hanwen Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Neuroscience and Experimental & Molecular Medicine.

In The Last Decade

Xiaoyin Lai

7 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyin Lai China 7 313 197 99 59 37 10 408
Aurora Mazzeo Italy 12 210 0.7× 94 0.5× 49 0.5× 20 0.3× 48 1.3× 18 389
Jiean Xu China 12 240 0.8× 83 0.4× 93 0.9× 52 0.9× 152 4.1× 25 526
Tengfeng Yan China 11 228 0.7× 156 0.8× 27 0.3× 38 0.6× 36 1.0× 31 375
Stefan Reischl Germany 11 131 0.4× 82 0.4× 80 0.8× 50 0.8× 33 0.9× 27 412
Qun Chu China 10 334 1.1× 90 0.5× 18 0.2× 52 0.9× 61 1.6× 10 435
Guangwen Long China 7 544 1.7× 516 2.6× 32 0.3× 46 0.8× 40 1.1× 12 700
Joseph H. Garcia United States 9 152 0.5× 67 0.3× 24 0.2× 45 0.8× 31 0.8× 34 360
Ann‐Britt Nygaard Denmark 6 278 0.9× 268 1.4× 54 0.5× 38 0.6× 13 0.4× 8 437
Mingfeng He China 10 197 0.6× 151 0.8× 50 0.5× 24 0.4× 29 0.8× 26 407
Rajendra P. Pangeni United States 13 357 1.1× 138 0.7× 33 0.3× 24 0.4× 35 0.9× 17 484

Countries citing papers authored by Xiaoyin Lai

Since Specialization
Citations

This map shows the geographic impact of Xiaoyin Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyin Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyin Lai more than expected).

Fields of papers citing papers by Xiaoyin Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyin Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyin Lai. The network helps show where Xiaoyin Lai may publish in the future.

Co-authorship network of co-authors of Xiaoyin Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyin Lai. A scholar is included among the top collaborators of Xiaoyin Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyin Lai. Xiaoyin Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liu, Yun, Yifan Zhang, Zhifu Xie, et al.. (2025). A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of BGT-002, a Novel ATP-Citrate Lyase Inhibitor, in Healthy Chinese Subjects. Drug Design Development and Therapy. Volume 19. 1783–1794.
2.
Lai, Xiaoyin, Xuelian Yang, Lu Wang, et al.. (2021). Upregulation of circ‐FBL promotes myogenic proliferation in myasthenia gravis by regulation of miR‐133/PAX7. Cell Biology International. 45(11). 2287–2293. 12 indexed citations
3.
Xu, Limin, Hai‐Feng Ji, Yufeng Jiang, et al.. (2020). Exosomes Derived From CircAkap7-Modified Adipose-Derived Mesenchymal Stem Cells Protect Against Cerebral Ischemic Injury. Frontiers in Cell and Developmental Biology. 8. 569977–569977. 37 indexed citations
4.
Yang, Xuelian, Liying Cai, & Xiaoyin Lai. (2019). Parkinson′s disease with paroxysmal breath holding and hypoxemia as the manifestation of dyskinesia: a case report. Chin J Neurol. 52(8). 646–649.
5.
Li, Wenyan, Ping Zhao, Liwen Chen, et al.. (2019). Impact of CYP2C9 , VKORC1 , ApoE and ABCB1 Polymorphisms on Stable Warfarin Dose Requirements in Elderly Chinese Patients. Pharmacogenomics. 21(2). 101–110. 9 indexed citations
6.
Lai, Xiaoyin, Xuelian Yang, Mei Jiang, et al.. (2018). Motor neurone disease-associated neck pain misdiagnosed as cervical spondylosis: A case report and literature review. Journal of Clinical Neuroscience. 55. 112–115.
7.
Wang, Lu, et al.. (2018). Integrin α5β1-Ang1/Tie2 receptor cross-talk regulates brain endothelial cell responses following cerebral ischemia. Experimental & Molecular Medicine. 50(9). 1–12. 22 indexed citations
8.
Jiang, Mei, Hairong Wang, Mingming Jin, et al.. (2018). Exosomes from MiR-30d-5p-ADSCs Reverse Acute Ischemic Stroke-Induced, Autophagy-Mediated Brain Injury by Promoting M2 Microglial/Macrophage Polarization. Cellular Physiology and Biochemistry. 47(2). 864–878. 259 indexed citations
9.
Yang, Xuelian, Haifeng Ji, Xiaoyin Lai, et al.. (2018). Downregulation of circ_008018 protects against cerebral ischemia–reperfusion injury by targeting miR-99a. Biochemical and Biophysical Research Communications. 499(4). 758–764. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026